BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34839558)

  • 1. SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma.
    Meng F; Yuan Y; Ren H; Yue H; Xu B; Qian J
    Cancer Sci; 2022 Feb; 113(2):622-633. PubMed ID: 34839558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
    Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
    Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
    Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
    J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
    Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
    Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.
    Benhassine M; Le-Bel G; Guérin SL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
    Li J; Liu X; Li C; Wang W
    J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway.
    Yan F; Liao R; Silva M; Li S; Jiang Y; Peng T; Lazarovici P; Zheng W
    J Cell Mol Med; 2020 Jun; 24(11):6208-6219. PubMed ID: 32347651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
    Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression.
    Li H; Li Q; Dang K; Ma S; Cotton JL; Yang S; Zhu LJ; Deng AC; Ip YT; Johnson RL; Wu X; Punzo C; Mao J
    Cell Rep; 2019 Dec; 29(10):3200-3211.e4. PubMed ID: 31801083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways.
    Xie X; Xie S; Xie C; Fang Y; Li Z; Wang R; Jiang W
    J Cell Mol Med; 2019 Nov; 23(11):7545-7553. PubMed ID: 31508890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of RASSF1A in uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region.
    Brantley MA; Harbour JW
    Cancer Res; 2000 Aug; 60(16):4320-3. PubMed ID: 10969768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y; Chung KC
    J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
    Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
    Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.
    Dong L; You S; Zhang Q; Osuka S; Devi NS; Kaluz S; Ferguson JH; Yang H; Chen G; Wang B; Grossniklaus HE; Van Meir EG
    Clin Cancer Res; 2019 Apr; 25(7):2206-2218. PubMed ID: 30563937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
    Jiang Z; Liu F
    Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2.
    Huang XM; Shi SS; Jian TM; Tang DR; Wu T; Sun FY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2880-2887. PubMed ID: 31002139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.